Clinical Trials Directory

Trials / Sponsors / Optinose US Inc.

Optinose US Inc.

Industry · 13 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
RecruitingEfficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinus
Chronic Rhinosinusitis Without Nasal Polyps
Phase 32025-07-28
TerminatedA Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19
Covid19
Phase 12021-09-01
CompletedStudy Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhin
Chronic Rhinosinusitis
Phase 32019-06-06
RecruitingOPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Bilateral Nasal Polyposis
Phase 32018-12-31
CompletedStudy Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhin
Chronic Rhinosinusitis
Phase 32018-11-27
CompletedEfficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video
Nasal Polyposis
Phase 32018-06-07
CompletedA Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE
Mild to Moderate Asthma
Phase 12014-09-01
CompletedStudy Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone P
Bilateral Nasal Polyposis
Phase 32013-11-19
CompletedEfficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using
Bilateral Nasal Polyposis
Phase 32013-10-30
CompletedStudy Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID)
Chronic Sinusitis With or Without Nasal Polyps
Phase 32013-09-01
Completed12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device
Nasal Polyps
Phase 32013-09-01
CompletedBioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects
Migraine
Phase 12012-01-01
CompletedSafety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device
Migraine Headache
Phase 32011-01-01